All data are based on the daily closing price as of September 6, 2024
e
Ever Supreme Bio Technology
6712.TWO
5.58 USD
0.06
+1.09%
Overview
Last close
5.58 usd
Market cap
409.38M usd
52 week high
7.13 usd
52 week low
5.35 usd
Target price
N/A usd
Valuation
P/E
28.48
Forward P/E
N/A
Price/Sales
17.4359
Price/Book Value
9.2683
Enterprise Value
425.78M usd
EV/Revenue
16.5594
EV/EBITDA
21.5338
Key financials
Revenue TTM
25.71M usd
Gross Profit TTM
N/A usd
EBITDA TTM
13.14M usd
Earnings per Share
0.2 usd
Dividend
0.17 usd
Total assets
N/A usd
Net debt
N/A usd
About
Ever Supreme Bio Technology Co., Ltd engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells. Its products include UMC01, a drug candidate in Phase I clinical trials for the treatment of myocardial infarction and stroke; ADCV01, a drug candidate in Phase II clinical trials for the treatment of malignant brain tumor; CAR001, a chimeric antigen receptor immune cells product; and bone-marrow stem cells (BMSC), used to treat chronic stroke, degenerative osteoarthritis, and spinal cord injuries. The company was incorporated in 2016 and is based in Taichung, Taiwan.